Specifically, the increased expression of Claudin-1 in colon cancer correlated with metastasis and poor prognosis40–42, and with poor outcome in high grade invasive ductal carcinoma of the breast where it correlated with the molecular subtype43. This evidence concerns the gene CLDN1 and invasive ductal breast carcinoma.